Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)

• Status: Completed
• Trial end date: 2003-03-04
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and effectiveness of two approved drugs in lowering high cholesterol when taken together, compared to taking only one of the drugs.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Simvastatin

Criteria

Inclusion Criteria:

• Elevated cholesterol level

Exclusion Criteria:

• Liver disease

• Known allergies to study drugs